Beautiful Virgin Islands

Sunday, Oct 05, 2025

Joe Biden’s ‘America First’ Vaccine Strategy

Joe Biden’s ‘America First’ Vaccine Strategy

Although the new administration has reversed many of the isolationist policies of its predecessor, the United States’ commitment to its own vaccine procurement remains unchanged.
When it came to shifting the United States’ pandemic posturing, Joe Biden wasted no time. Within hours of his inauguration, the president retracted the previous administration’s decision to withdraw the U.S. from the World Health Organization and signed executive orders mandating mask wearing on federal property and public transportation.

The next day, his chief medical adviser, Anthony Fauci, confirmed that the U.S. would also be supporting COVAX, the international initiative aimed at equalizing vaccine distribution around the world.

The moves were widely received as a necessary corrective to American isolationism under Donald Trump. With Biden in charge, the U.S. appeared to finally be resuming its role as a global leader—one that, as the president pledged in his inaugural address, would “lead not merely by the example of our power, but by the power of our example.”

The reality, however, has proved far less poetic: Within a week of the WHO and COVAX announcements, the Biden administration also said that it hoped to ramp up the U.S.’s vaccine rollout to 1.5 million vaccinations a day—an effort that will be buoyed by the purchase of a further 200 million doses of the Pfizer-BioNTech and Moderna vaccines. The new deals put the country’s projected vaccine supply at 1.2 billion doses, according to the Duke University Global Health Innovation Center’s vaccine-procurement tracker—enough to inoculate the American population twice over.

Far from supporting more equitable vaccine distribution around the world, the U.S. under Biden is continuing to undermine it, to the detriment of poorer nations, as well as itself.

To be fair to the U.S., it’s not alone. High-income countries, virtually all of which have signed on to COVAX, have secured nearly 60 percent of the 7.2 billion vaccine doses purchased so far, according to Duke, despite representing just 16 percent of the global population. Though many of these countries have reserved enough doses to inoculate their population several times over, that hasn’t prevented them from sparring over who gets the doses first.

The European Union, in an apparent bid to make up for the shortfall in its own vaccine supply, even went so far as to announce export controls on doses leaving the bloc—a decision that was quickly reversed following an uproar.

While nothing is inherently wrong with wealthy countries wanting to secure enough supply to protect their population, their actions become an issue when they prevent low- and middle-income countries from doing the same.

Early on in the pandemic, experts warned that vaccine nationalism—in which countries prioritize their own domestic needs at the expense of everyone else—would hinder global economic recovery and prolong the public-health crisis.

Nearly a year on, those concerns have largely been borne out: High-income countries that bought themselves to the front of the vaccine line have all but cleared the shelves, leaving little in the way of short-term supply for the world’s poorest countries, the large majority of which haven’t received any vaccine doses.

At the same time, uncontrolled outbreaks in Brazil, Britain, and South Africa have spurred new, more transmissible variants of the coronavirus that have since spread around the world, proving that if the virus is left endemic anywhere, it can still pose a threat everywhere.

Until recently, the U.S. didn’t feign to care about equal distribution. As with most of its policies, the Trump administration opted for an “America First” approach to public health, prioritizing domestic vaccination efforts over multilateral initiatives. In keeping with this approach, one of Trump’s final acts as president was an attempt to scrap $4 billion in funding earmarked for Gavi—one of the organizations leading COVAX alongside the WHO—from Congress’s recent spending bill. That request was ultimately rebuffed.

Though Biden has sought to reverse many of Trump’s policies, the U.S.’s commitment to prioritizing its own vaccine procurement remains unchanged. From a global-distribution standpoint, the U.S. joining COVAX doesn’t change the fact that most wealthy countries have already reserved the lion’s share of the world’s available vaccine supply.

“We’re sort of past trying to say, ‘Okay rich countries, stop buying doses,’” Andrea Taylor, the assistant director of programs at Duke’s Global Health Innovation Center, told me. As far as equitable access is concerned, “that ship has sailed.”

This doesn’t mean that nothing can be done to rectify the situation. Wealthy countries could simply contribute more funding to COVAX, which would give the initiative the buying power it needs to reserve a fair share of doses for the countries relying on it. The initiative announced this week that it will aim to distribute more than 300 million doses—enough to cover approximately 3 percent of receiving countries’ populations—by the end of June.

Though COVAX has raised more than $6 billion so far, a Gavi spokesperson told me that it will need a further $2 billion to hit its 2021 targets. Still, as Taylor noted, most of the priority manufacturing capacity for this year has already been reserved, meaning that even if COVAX were to secure more doses, companies wouldn’t necessarily have the means to produce them all immediately. Indeed, current models project that it will take years before there are enough doses to meet global demand.

The other, perhaps more realistic option is for high-income countries to donate doses directly to low-income ones. Under this solution, which has already been championed by Norway, donations would occur in tandem with richer countries’ domestic vaccination programs, ensuring that poorer states aren’t put in the position of having to wait until the world’s wealthiest populations are vaccinated before they can receive lifesaving supplies.

The proposal has been supported by the WHO, albeit with limited take-up: Canada, which has secured more than enough doses to vaccinate its population, has committed to sharing its excess doses only after its population has been inoculated; Britain, which has also secured well over the number of doses needed to vaccinate its population, has suggested that it too would consider donating its extra doses, but said it’s “a bit too early” to specify how and when that would occur. While both countries’ leaders have extolled multilateral efforts to ensure more equitable distribution around the world, neither has been willing to commit to it in practice.

Politically, this is a tough sell for any world leader—not least for Biden, who campaigned on the promise of delivering the U.S. from a public-health crisis that is projected to claim more than half a million American lives. But there are compelling reasons for why his government should commit to sharing its vaccine supply—if not for the sake of poorer countries, then for its own people.

The first is economic: Though it’s projected to cost $25 billion to supply enough vaccines for low-income countries, modeling by the Rand Corporation projects that unequal distribution would cost the global economy $1.2 trillion a year in GDP, owing to the delayed recovery of key sectors such as the tourism and retail industries.

Another study, by the International Chamber of Commerce, offers an even more dire assessment, projecting that the global economy stands to lose as much as $9.2 trillion unless equitable access is assured.

The second, perhaps more significant reason has to do with public health: The emergence of new variants has demonstrated the coronavirus’s capacity to evolve and mutate into more transmissible forms. Ashish Jha, the dean of Brown University’s School of Public Health, warned in a series of tweets that if coronavirus outbreaks are left uncontrolled anywhere, they could jeopardize the safety of people everywhere, including countries that are widely vaccinated.

“We might see [a] rise of variants that eventually escape the vaccines and make everyone vulnerable again,” Jha wrote. “It’s the nightmare scenario of the never-ending pandemic.”

The Biden administration has discussed ensuring more equitable distribution, Ezekiel Emanuel, an oncologist, bioethicist, and a member of President Biden’s Transition COVID-19 Advisory Board, told me.

It’s something that Emanuel has thought a lot about too. In September, he co-wrote a report advocating for an ethical framework for global vaccine allocation, in which vaccine distribution would be based not on the size of a country’s population (as is currently the case under COVAX), but with the primary focus of reducing the mortality and economic impact of the pandemic.

“Countries have a good reason to try and get to herd immunity in their own countries and that’s a very important consideration,” he said, adding that “once they get to herd immunity, there is a very good rationale for the next doses to go to countries where they can save lives.”

Though Emanuel said it’s unrealistic to expect wealthy countries to follow Norway’s lead (“It’s a lot easier when you’re a [small] country”), he noted that the rise of new variants gives every country a stake in more equitable distribution. “That gives us a big interest in making sure the whole world is addressed,” he said. “This is more than just our borders.”

My colleague Tom McTague has noted how Britain could still rewrite its pandemic story. The same could be true for the U.S. and other wealthy countries—but only if they take the steps necessary to ensure that the pandemic ends beyond their own borders. Until they do, the prevailing narrative will be one of an avoidable nightmare from which even the most vaccinated countries can’t wake up.
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
FBI Removes Agents Who Kneeled at 2020 Protest, Citing Breach of Professional Conduct
Trump Alleges ‘Triple Sabotage’ at United Nations After Escalator and Teleprompter Failures
Shock in France: 5 Years in Prison for Former President Nicolas Sarkozy
Tokyo’s Jimbōchō Named World’s Coolest Neighbourhood for 2025
European Officials Fear Trump May Shift Blame for Ukraine War onto EU
BNP Paribas Abandons Ban on 'Controversial Weapons' Financing Amid Europe’s Defence Push
Typhoon Ragasa Leaves Trail of Destruction Across East Asia Before Making Landfall in China
The Personality Rights Challenge in India’s AI Era
Big Banks Rebuild in Hong Kong as Deal Volume Surges
Italy Considers Freezing Retirement Age at 67 to Avert Scheduled Hike
Italian City to Impose Tax on Visiting Dogs Starting in 2026
Arnault Denounces Proposed Wealth Tax as Threat to French Economy
Study Finds No Safe Level of Alcohol for Dementia Risk
Denmark Investigates Drone Incursion, Does Not Rule Out Russian Involvement
Lilly CEO Warns UK Is ‘Worst Country in Europe’ for Drug Prices, Pulls Back Investment
Nigel Farage Emerges as Central Force in British Politics with Reform UK Surge
Disney Reinstates ‘Jimmy Kimmel Live!’ after Six-Day Suspension over Charlie Kirk Comments
U.S. Prosecutors Move to Break Up Google’s Advertising Monopoly
Nvidia Pledges Up to $100 Billion Investment in OpenAI to Power Massive AI Data Center Build-Out
U.S. Signals ‘Large and Forceful’ Support for Argentina Amid Market Turmoil
×